293 results
Left main and bifurcation PCI in NSTEMI
19 May 2022 – From EuroPCR 2022
View cases on OCT and jailed balloon technique, imaging-guided LMS bifurcation PCI, crossover stenting in a bifurcation coronary lesion to find out more about left main and bifurcation PCI in NSTEMI.
Managing complications during PCI for NSTEMI
19 May 2022 – From EuroPCR 2022
Watch this session to learn how to face various complications during PCI for NSTEMI thanks to a selection of cases presented at EuroPCR 2022: a inadvertent wire loss, the rescue of a ruptured radial artery with persistent bleeding, as well as a missing/embolised fully deployed ostial RCA...
Challenging and atypical lesions in NSTEMI
19 May 2022 – From EuroPCR 2022
Consult this session on NSTEMI to discover some challenging cases with atypical lesions, such as: a very long sequential SVG in an acute setting, a right coronary artery ostial in-stent restenosis, a severe three-vessels coronary artery disease, and more!
How to deal with complications during primary PCI
19 May 2022 – From EuroPCR 2022
Watch these videos to learn more about the management of complications during primary PCI, such as coronary perforations, multiple acute-re-occlusions, stent dislodgment, acute thrombosis, and more!
Thinking beyond the coronary lesion in NSTEMI
19 May 2022 – From EuroPCR 2022
Thanks to these six clinical case submissions, including a case on an unusual risk factor, the impact of cigarette, malignant gastric cancer and severe coronary artery disease, you will understand how to think beyond the coronary lesion in NSTEMI.
PCI in acute coronary syndrome: when do we need assist device?
19 May 2022 – From EuroPCR 2022
Take the case of a 70-year-old-patient suffering obesity, DM, HTN, HLD, who presented with an anterior STEMI and shock, or the one of a 74-year-old woman with ACS and a very low ejection fraction, and get to understand when assist devices can be used.
Dealing with calcified lesions: friends and enemies
19 May 2022 – From EuroPCR 2022
Learn tips and tricks when addressing calcified lesions, including the optimal application of imaging insights, IVUS-guidance for treatment of Type 3 perforation and more!
Innovations in coronary physiology
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to compare diagnostic accuracy of one versus two angiographic views, study normal and ANOCA patients, and find out more about a novel approach to manage coronary microvascular dysfunction.
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary artery disease: MASTER DAPT, CRUZ-HBR, DISCO RADIAL, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary artery disease! Abbreviated DAPT after complex PCI in high bleeding risk patients, comparing conventional and haemostatic dressings in radial access, angio-based QFR virtual PCI vs. conventional angio-guided PCI, CRUZ-HBR, CT-guided invasive coronary angiography in patients with...
When the barrier is crossed: dealing with iatrogenic dissection and perforation
17 May 2022 – From EuroPCR 2022
Consult this session to learn more about what to do when facing iatrogenic dissection and perforation, and discover some novel approaches and techniques to seal them, thanks to a selection of cases: sub-intimal stent placement after dissection, wire fracture followed by coronary dissection, and much more!
NSTEMI PCI: LIVE case from St Thomas' Hospital - London, United Kingdom
17 May 2022 – From EuroPCR 2022
Watch the case of a 65-year-old ex-smoker, male patient, with hypertension and cholesterol, who presented with chest pain at rest, symptomatic with nausea and dizziness, and find out how this NSTE-ACE patient was treated.
Repeat NSTEMI late after self-expanding TAVR
17 May 2022 – From EuroPCR 2022
Discover the case of a 79 year-old man presenting to the ER with NSTEMI and chest pain, with an history of NSTEMI with PCI and TAVR (CTO of the dominated RCA and intermediate stenosis of the proximal LAD). Angiography reveals a tight stenosis of proximal and...
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction
03 Apr 2022
Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.
Author
OCT conundrum during PCI
18 Mar 2022
How did one coronary lesion become three lesions by OCT?
Author
Risk of cardiovascular hospital admission after exposure to fine particulate pollution
23 Feb 2022
This current study explored the effect of heavy particle pollution on total cardiovascular admissions, whilst also looking at risk for specific cardiovascular diagnoses, such as angina, myocardial infarction, and ischaemic stroke.
Reviewer
Reviewer
Improved 3-year cardiac survival after IVUS-guided long DES implantation: a patient-level analysis from 2 randomized trials
02 Feb 2022
This study aimed to increase the power to detect differences in patient survival (freedom from cardiac deaths) with IVUS versus angiography guidance by pooling the individual patient data from the IVUS-XPL and ULTIMATE trials.
Reviewer
Ticagrelor monotherapy after PCI in high-risk patients with prior MI: a prespecified TWILIGHT substudy
31 Jan 2022
In this prespecified subgroup analysis of the TWILIGHT trial, the authors report the impact of prior MI on treatment effects of ticagrelor monotherapy compared to ticagrelor and aspirin in patients at least three months post PCI...
Reviewer
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
Fractional flow reserve to guide treatment of patients with multivessel coronary artery disease - the FUTURE trial
05 Nov 2021
The FUTURE Trial is a prospective randomised, multicentre, open label superiority trial comparing an FFR guided treatment strategy to traditional angiography guided treatment strategy on clinical outcomes in an all-comer population with multivessel coronary artery disease.
Reviewer
iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation
04 Nov 2021
Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...
Author
